Xeris Biopharma Holdings (XERS) Stock Price & Financial Analysis
Xeris Biopharma Holdings Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Xeris Biopharma Holdings
What is the current stock price for XERS?
As of the latest trading session, XERS stock trades at $6.04. The 52-week range is $3.81–$10.08, with a day range of $5.88–$6.14.
What is the P/E ratio for XERS?
Xeris Biopharma Holdings's trailing P/E ratio is 1963.2, meaning investors pay $1963.2 for every $1 of annual earnings. Xeris Biopharma Holdings operates in the Healthcare sector.
Does XERS pay dividends?
Xeris Biopharma Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for XERS?
Based on 2 analysts, the consensus for XERS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of XERS?
Xeris Biopharma Holdings's market capitalization is $1.09B, classifying it as a small-cap company. Xeris Biopharma Holdings operates in the Healthcare sector within the Biotechnology industry.